DCSSC

Clinical trials for DCSSC explained in plain language.

Never miss a new study

Get alerted when new DCSSC trials appear

Sign up with your email to follow new studies for DCSSC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Cancer drug repurposed to fight rare skin disease in small safety trial

Symptom relief Completed

This early-phase study tested whether a drug used for lymphoma, brentuximab vedotin, is safe for people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis). The drug targets overactive immune cells that may drive the disease. Only 17 people took part, and the…

Matched conditions: DCSSC

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief

Last updated Jun 27, 2026 12:29 UTC

DCSSC

Get alerted when new DCSSC trials appear

Cancer drug repurposed to fight rare skin disease in small safety trial